Large patient base Maple serves over 8 million patients with on-demand access to Canadian-licensed doctors and specialists, indicating a broad potential for upsell or cross-sell of additional virtual care services, premium memberships, or enterprise healthcare solutions to partner organizations and government partners.

Enterprise partnerships With 7,000 businesses and government partners already connected to Maple, there is a clear entry point for expanding B2B offerings such as managed care programs, integrated telehealth platforms, or white-label solutions for larger corporate and public sector clients.

Revenue scale Current revenue is in the high hundreds of millions range and funding totals around modest levels, suggesting room to target growth opportunities in mid-market healthcare plans, enterprise licensing, or performance-based pricing with partners and clinics.

Tech stack leverage Maple already uses a diverse tech stack including analytics, communications, and development frameworks. This enables sales to position integrations with analytics dashboards, CRM automation, and partner-facing portals to streamline adoption for new clients.

Strategic growth signals Publicized investor interest and coverage around the CART stock and related growth narratives imply market enthusiasm for scalable, value-driven health tech platforms, presenting an angle for joint marketing with investors or promotional partnerships to attract new enterprise customers.